Jan 17, 2026 · 44 min
Cramer links market volatility to business quality and chip demand
Mad Money w/ Jim Cramer 1/16/26
The episode frames an unsettled market through practical tests for cash flow, diversification, position sizing, and semiconductor supply.
- 1Cramer favors business quality, cash flow, and diversification over judging holdings by share price alone.
- 2Pharmaceutical speculation carries outsized risk when investors rely on drug-development stories and underweight disciplined position sizing.
- 3Micron’s planned $100 billion U.S. expansion underscores the continuing importance of memory-chip supply for data centers.
Don't miss
Cramer connects Micron’s planned $100 billion New York facility to severe memory-chip shortages and data-center demand.
The brief
Jim Cramer opens against an erratic market, using calls about Reddit, Lam Research, and Boeing to stress volatility, semiconductor exposure, cash flow, and the search for future winners.
The discussion moves from J.B. Hunt’s mixed earnings to a broader question: does transportation strength signal that the freight recession may be ending?
Questive and other pharmaceutical calls sharpen the risk case, as Cramer warns that drug-development narratives can overwhelm business quality and sensible position sizing.
Portfolio reviews across healthcare, financials, machinery, semiconductors, utilities, and technology make diversification concrete, with holdings judged by businesses rather than share prices.
The standout arrives with Micron’s planned $100 billion New York facility, which Cramer connects to a severe shortage of memory chips used in data centers.
What was said on this episode
33 statements · 22 positive · 8 negative · 3 mixed
Allowing penalty-free 401(k) home purchases would lift D.R. Horton and other homebuilders.
“It would certainly send the stock of D.R. Horton much higher, along with the rest of the homebuilders.”
Listen at 1:57
3M is attractive ahead of its earnings report.
“I like 3M ahead of the quarter.”
Listen at 2:16
Investors should buy five travel-related companies ahead of earnings.
“I would buy United Airlines ahead of a quarter, along with Delta, American Express, Booking Holdings, and Marriott.”
Listen at 2:55
The upcoming PCE price index will show restrained inflation.
“I think it will show a restrained set of numbers.”
Listen at 4:25
Trump will choose a Fed chair who aggressively implements rate cuts.
“Trump's going to pick someone to be Fed chair who will ram through cuts.”
Listen at 4:31
Procter & Gamble is unlikely to produce strong earnings results.
“I don't expect any fireworks or anything really good out of the company”
Listen at 4:38
GE Aerospace will report spectacular results.
“I can't imagine it'll be anything other than. Spectacular.”
Listen at 5:15
Crude below $60 would make strong SLB results difficult.
“Below $60 a barrel, I think that it's very hard for SLB to deliver special numbers when it reports on Friday.”
Listen at 7:47
Reddit remains a favorable investment and potential future winner.
“I include Reddit. So I'm not backing down. I like the company Reddit right here.”
Listen at 9:00
Investors can buy some Lam Research but should limit purchases amid overbought conditions.
“I actually think that you can buy some, but the market's very overbought”
Listen at 9:48
Investors should continue owning Boeing.
“I insist that you continue to own it.”
Listen at 10:44
J.B. Hunt could profit substantially when freight markets recover.
“when the freight market turns around, J.B. Hunt should be able to make a fortune.”
Listen at 15:32
J.B. Hunt stock appears expensive at over 27 times estimated earnings.
“J.B. Hunt's stock now feels pretty darn expensive, trading at over 27 times this year's earnings estimates.”
Listen at 16:20
FedEx Freight could be attractive if spun off at a reasonable valuation.
“FedEx freight could be a very compelling piece of paper if it gets spun off at a reasonable price.”
Listen at 17:15
Existing Equestive holders should not sell because FDA approval remains possible.
“I wouldn't be looking to sell it down here after the big move lower, because there's still some hope remaining that Anafilm could be approved by the FDA”
Listen at 22:45
New investors should avoid buying Equestive.
“if you don't already own it, there's no reason to stick your neck out and buy some.”
Listen at 23:00
Large-cap pharmaceutical stocks offer less upside but lower FDA-driven crash risk.
“those stocks offer less potential upside, at least in the near term, but they're not going to get cut in half over the course of a week thanks to a single decision from the FDA.”
Listen at 23:58
Investors should sell GE Healthcare.
“And I think you should sell the stock.”
Listen at 25:35
Investors should choose Crinetics as a pharmaceutical speculation.
“I say go with CRNX”
Listen at 26:35
The portfolio should replace Vici with Johnson & Johnson.
“So let's get rid of Vici. I want to add J&J.”
Listen at 28:58
The Boeing, Agnico Eagle, Morgan Stanley, Caterpillar, and TSM portfolio needs no changes.
“Bingo! Do nothing. I love it.”
Listen at 30:10
The Philip Morris, Amazon, NVIDIA, AEP, and Uber portfolio is well diversified.
“Fantastic.”
Listen at 31:04
The AbbVie, Honeywell, Energy Transfer, Santander, and Medtronic portfolio should be retained unchanged.
“And I see nothing to do there other than keep it.”
Listen at 31:56
The portfolio should replace Ares Capital with Johnson & Johnson.
“I'm going to get you out of that. I'm going to also put you in J&J.”
Listen at 32:59
Investors seeking that semiconductor area should own NVIDIA instead of Super Micro.
“You want to own that area? You own NVIDIA. Period. End of story.”
Listen at 35:16
Alkermes is not recommended for investment.
“I do not recommend the stock.”
Listen at 35:33
UiPath has meaningful upside potential.
“I think the upside is what beckons there.”
Listen at 36:42
Smith & Nephew shares should be sold because the business is commoditized.
“they have to agree. They have to be sold, okay? This group I do not like”
Listen at 36:56
Medline is strongly recommended for purchase.
“I think it is a... Buy, buy, buy! Buy, buy, buy!”
Listen at 37:27
Investors should buy STMicroelectronics.
“I would be a buyer of ST Micro.”
Listen at 37:55
Investors should take profits and exit Constellation Energy.
“You've got a really big gain in the stock, and it's time to move on.”
Listen at 38:36
Memory-chip and flash-memory prices will continue rising amid data-center demand.
“prices will just keep going higher because only Jensen, Mong, and NVIDIA seem to appreciate the scale of the opportunity here.”
Listen at 41:43
Micron, Western Digital, Seagate, and SanDisk stocks can continue rising.
“Can these stocks keep going higher, though? The answer is yes”
Listen at 42:20
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Books & mentions
Some links are affiliate links — PodLume may earn a commission if you buy.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.